Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2014 October;105(5) > Minerva Medica 2014 October;105(5):391-411

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Medica 2014 October;105(5):391-411

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Staging of esophageal and gastric cancer in 2014

Yegin E. G., Duman D. G.

Department of Gastroenterology, Marmara University Faculty of Medicine, İstanbul, Turkey


PDF


Cancers of the upper gastrointestinal (GI) tract; esophageal and gastric carcinomas are highly lethal malignancies that have been ranked among the top 10 most frequent cancers and leading causes of cancer-related mortality. Universally, the tumor-node-metastasis (TNM) staging systems provided by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) are used for esophageal and gastric cancers. Accurate locoregional staging has become critical for the application of appropriate stage-specific treatment options in the multimodality treatment era in order to achieve better patient outcomes. Endoscopic ultrasound (EUS) represents a valuable minimally invasive real-time imaging modality for the assessment of upper GI tract tumors providing evidence for tumor invasion depth and regional nodal involvement corresponding to the T and N status of the TNM staging system, but a clear understanding of its diagnostic performance, limits and complementary role to other imaging modalities is required. This review will focus on the literature about the role and value of EUS in the TNM staging of esophageal and gastric carcinoma. In addition, an overview of the description of the current 7th editions of TNM staging and the revisions of the last editions compared to previous editions are presented.

top of page